| Cash and cash equivalents |
303K |
| Trade accounts receivable, net of allowance of $0 and $65,000 |
| Grants receivable |
| Other receivables |
| Prepaid research expenses |
| Prepaid expenses and other assets |
59K |
| Total current assets |
7.33M |
| Property and equipment, net of accumulated depreciation of $231,988 and $197,971 |
6K |
| Patents, net of accumulated amortization of $1,941 and $50,725 |
8.2M |
| Deposit |
26K |
| Total assets |
15.56M |
| Accounts payable and accrued expenses |
64K |
| Accrued salaries and benefits |
| Deferred revenue |
1.25M |
| Total current liabilities |
2.93M |
| Deferred compensation |
| Deferred rent |
| Total liabilities |
| Commitments and contingencies |
0 |
| Preferred stock, $0.01 par value, 2,000,000 shares authorized; 5,250 series B issued and 1 outstanding at June 30, 2011 and December 31, 2010 |
0 |
| Common stock, $0.01 par value, 5,000,000 shares authorized; 2,570,531 and 2,143,631 issued, 2,562,488 and 2,135,588 outstanding at June 30, 2011 and December 31, 2010, respectively |
0 |
| Paid-in capital in excess of par value |
| Treasury stock, 8,043 shares, at cost at June 30, 2011 and December 31, 2010 |
-264K |
| Accumulated deficit |
-137.85M |
| Total stockholders' equity |
| Total liabilities and stockholders' equity |
15.56M |
